tiprankstipranks
Trending News
More News >
Axilion Smart Mobility Ltd. (IL:AILN)
:AILN
Israel Market

Axilion (AILN) AI Stock Analysis

Compare
0 Followers

Top Page

IL

Axilion

(AILN)

Rating:45Neutral
Price Target:
33.00
▲(56.40%Upside)
Axilion's overall stock score reflects significant financial challenges, a lack of profitability, and a weak valuation. Short-term technical strength provides some positive momentum, but long-term technical signals and financial health concerns overshadow it.

Axilion (AILN) vs. iShares MSCI Israel ETF (EIS)

Axilion Business Overview & Revenue Model

Company DescriptionAxilion (AILN) is a technology company that specializes in artificial intelligence and smart city solutions. The company focuses on developing and deploying advanced AI-driven platforms to optimize urban mobility, reduce traffic congestion, and enhance city infrastructure. Axilion offers solutions that integrate seamlessly with existing city systems to provide real-time data analytics, predictive insights, and automated decision-making capabilities.
How the Company Makes MoneyAxilion generates revenue through the sale and implementation of its AI-based smart city solutions, which are typically offered as software-as-a-service (SaaS) models to municipalities and urban planners. Key revenue streams include licensing fees for its software platforms, subscription fees for ongoing access and updates, and professional services for customization and integration. The company may also engage in strategic partnerships with city governments and infrastructure providers to expand its reach and enhance its offerings.

Axilion Financial Statement Overview

Summary
Axilion is facing considerable financial difficulties, with negative income margins, declining equity, and negative cash flows. Despite manageable debt levels, the reliance on equity financing and lack of operational profitability signal major financial challenges.
Income Statement
25
Negative
Axilion's income statement reveals significant challenges. Despite an increase in revenue from 2023 to 2024, the company has consistently reported negative gross profit margins, indicating that its costs exceed its revenues. The net profit margin remains negative, showcasing ongoing losses. EBIT and EBITDA margins are also negative, reflecting a lack of operational profitability. The revenue growth rate of 15.78% from 2023 to 2024 is a positive note, but it is overshadowed by the persistent negative margins.
Balance Sheet
30
Negative
The balance sheet shows a company that is heavily reliant on equity financing with a low debt-to-equity ratio of 0.29 in 2024. However, the equity ratio has decreased significantly from 2023 to 2024, indicating declining financial stability. Return on Equity (ROE) remains negative due to sustained losses, and the overall financial health is weak despite manageable debt levels.
Cash Flow
20
Very Negative
Axilion's cash flow statements highlight severe liquidity issues, with negative operating and free cash flows. Although the operating cash flow to net income ratio is close to 1, indicating consistency in cash burn relative to net losses, the lack of positive free cash flow growth and negative free cash flow to net income ratio underscores the firm's inability to generate cash from operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.91M2.22M1.91M1.26M2.14M1.53M
Gross Profit1.91M-1.21M-1.45M-2.53M-2.96M1.63K
EBITDA-25.07M-21.82M-22.88M-21.82M-28.67M-281.25M
Net Income-24.24M-23.08M-24.24M-23.10M-30.24M-281.54M
Balance Sheet
Total Assets35.25M21.09M35.25M56.92M78.24M42.56M
Cash, Cash Equivalents and Short-Term Investments32.54M16.33M32.54M53.73M73.26M39.75M
Total Debt1.28M3.68M1.28M1.94M2.39M1.46M
Total Liabilities6.04M8.18M6.04M6.02M7.08M5.81M
Stockholders Equity29.21M12.91M29.21M50.90M71.16M36.76M
Cash Flow
Free Cash Flow-20.47M-20.42M-20.47M-19.70M-25.02M-13.60M
Operating Cash Flow-20.39M-20.39M-20.39M-19.59M-24.55M-13.19M
Investing Cash Flow7.38M16.84M7.38M347.00K-25.37M-588.64K
Financing Cash Flow-847.00K4.41M-847.00K-403.00K58.85M34.26M

Axilion Technical Analysis

Technical Analysis Sentiment
Positive
Last Price21.10
Price Trends
50DMA
25.36
Positive
100DMA
28.47
Positive
200DMA
36.05
Negative
Market Momentum
MACD
1.74
Negative
RSI
73.86
Negative
STOCH
76.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AILN, the sentiment is Positive. The current price of 21.1 is below the 20-day moving average (MA) of 27.67, below the 50-day MA of 25.36, and below the 200-day MA of 36.05, indicating a neutral trend. The MACD of 1.74 indicates Negative momentum. The RSI at 73.86 is Negative, neither overbought nor oversold. The STOCH value of 76.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:AILN.

Axilion Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$34.16B5.78-11.85%1.82%5.31%-18.32%
ILRZR
50
Neutral
181.81M
225.62%15.64%
45
Neutral
16.01M
15.78%27.57%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:AILN
Axilion
33.70
-13.04
-27.90%
IL:RZR
Razor Labs
454.40
-19.60
-4.14%

Axilion Corporate Events

Axilion Updates Convertible Securities Terms After Rights Offering
Feb 17, 2025

Axilion has announced an update to the terms of its convertible securities following a rights offering. This move signifies Axilion’s strategic financial adjustments which may affect its standing on the Tel Aviv Stock Exchange and could have implications for its stakeholders as the company continues to evolve in the financial market.

Axilion Announces Upcoming Investors’ Conference via Zoom
Feb 17, 2025

Axilion has announced an upcoming investors’ conference to be held via an online Zoom webinar. The conference is a significant event for stakeholders as it underscores Axilion’s commitment to transparency and engagement with investors, with the company’s securities being traded on the Tel Aviv Stock Exchange.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025